Live Breaking News & Updates on Neoleukin therapeutics daily
Stay updated with breaking news from Neoleukin therapeutics daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Neoleukin Therapeutics, Inc. (NASDAQ:NLTX – Get Free Report) was up 6.5% during trading on Thursday . The stock traded as high as $34.00 and last traded at $33.59. Approximately 51,187 shares traded hands during mid-day trading, an increase of 2% from the average daily volume of 50,104 shares. The stock had previously closed at $31.55. […]
Neoleukin Therapeutics (NASDAQ:NLTX) Trading Down 1.5% theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Neoleukin Therapeutics, Inc. (NASDAQ:NLTX – Get Free Report)’s stock price shot up 0.9% on Tuesday . The company traded as high as $32.26 and last traded at $32.00. 46,582 shares changed hands during trading, a decline of 7% from the average session volume of 50,104 shares. The stock had previously closed at $31.70. Neoleukin Therapeutics […]
Neoleukin Therapeutics, Inc. (NASDAQ:NLTX – Get Free Report) was the target of a large drop in short interest during the month of November. As of November 15th, there was short interest totalling 27,500 shares, a drop of 20.1% from the October 31st total of 34,400 shares. Approximately 0.4% of the company’s shares are sold short. […]
Neoleukin Therapeutics, Inc. (NASDAQ:NLTX – Get Free Report) saw a significant decline in short interest in November. As of November 15th, there was short interest totalling 27,500 shares, a decline of 20.1% from the October 31st total of 34,400 shares. Currently, 0.4% of the company’s stock are short sold. Based on an average daily volume […]
Neoleukin Therapeutics, Inc. (NASDAQ:NLTX – Get Free Report) saw a significant drop in short interest in the month of October. As of October 31st, there was short interest totalling 34,400 shares, a drop of 23.4% from the October 15th total of 44,900 shares. Approximately 0.5% of the company’s stock are short sold. Based on an […]
Shares of Neoleukin Therapeutics, Inc. (NASDAQ:NLTX – Free Report) are scheduled to reverse split on Monday, September 25th. The 1-5 reverse split was announced on Friday, September 22nd. The number of shares owned by shareholders will be adjusted after the market closes on Friday, September 22nd. Neoleukin Therapeutics Trading Down 1.6 % Shares of NLTX […]
Neoleukin Therapeutics, Inc. (NASDAQ:NLTX – Get Free Report) Director Bros. Advisors Lp Baker acquired 1,888,800 shares of the stock in a transaction dated Tuesday, August 15th. The stock was bought at an average cost of $0.63 per share, with a total value of $1,189,944.00. Following the completion of the purchase, the director now directly owns […]
Bros. Advisors Lp Baker Buys 1,888,800 Shares of Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) Stock themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Neoleukin Therapeutics, Inc. (NASDAQ:NLTX – Get Free Report) Director Bros. Advisors Lp Baker purchased 166,942 shares of the stock in a transaction on Thursday, August 17th. The stock was acquired at an average cost of $0.69 per share, for a total transaction of $115,189.98. Following the completion of the acquisition, the director now owns 5,612,949 […]